GO:0030892 mitotic cohesin complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030892 (mitotic cohesin complex) is a cellular_component defined as a cohesin complex that mediates sister chromatid cohesion during mitosis, with a subunit composition distinct from the meiotic cohesin complex.
• The mitotic cohesin ring is built around SMC1A/SMC3 heterodimers bridged by RAD21 (and its paralogs), with STAG1/STAG2 and PDS5/WAPL/ESCO accessory factors controlling its dynamic behavior.
• Cohesin is loaded in G1 and establishes cohesion during S phase, then is removed in two waves during mitosis: a prophase/phosphorylation-dependent pathway and a separase-dependent cleavage pathway.
• Beyond sister chromatid cohesion, mitotic cohesin contributes to kinetochore architecture by stabilizing the CCAN complex, linking cohesion to chromosome segregation fidelity.
• Mutations in cohesin subunits cause cohesinopathies such as Cornelia de Lange syndrome and Roberts syndrome, and somatic cohesin mutations are recurrent in myeloid malignancies and bladder cancer.
• CRISPR knockout, point-mutation, knock-in and overexpression models, combined with live-cell imaging, proteomics and CRISPR library screening, are central to dissecting mitotic cohesin function.
Description
The mitotic cohesin complex (GO:0030892) is the ring-shaped cohesin machinery that holds sister chromatids together from S phase until anaphase, ensuring accurate chromosome segregation in mitosis. Its subunit composition is distinct from the meiotic cohesin complex, reflecting specialized roles in mitotic chromosome architecture and kinetochore function. Cohesin is not a static clamp: its association with chromatin is dynamically regulated by loading factors, acetylation, phosphorylation and the release factor WAPL, allowing both stable cohesion and rapid dissolution at mitotic entry. Because cohesin sits at the intersection of chromosome segregation, gene regulation and DNA repair, its dysfunction has broad consequences for genome stability and human disease. Researchers studying GO:0030892 therefore need precise, cell-based models that can separate mitotic cohesion functions from meiotic or non-cohesion roles. This article summarizes the authoritative GO definition, the core subunits and assembly steps, the molecular mechanisms of cohesion establishment and removal, disease links, and the experimental methods used to interrogate the mitotic cohesin complex.
mitotic cohesin complex At A Glance
| GO ID | GO:0030892 |
|---|---|
| GO term | mitotic cohesin complex |
| Ontology | cellular_component |
| Synonym | nuclear mitotic cohesin complex |
| Definition | A cohesin complex that mediates sister chromatid cohesion during mitosis; has a subunit composition distinct from that of the meiotic cohesin complex. |
| Major function | Sister chromatid cohesion during mitosis and stabilization of kinetochore-associated CCAN complex |
| Core subunits | SMC1A, SMC3, RAD21, STAG1/STAG2 |
| Key regulators | WAPL, PDS5A/PDS5B, ESCO1/ESCO2, separase (ESPL1) |
| Cellular location | Nucleus, chromatin and centromere/kinetochore regions during mitosis |
What Is GO:0030892?
GO:0030892 (mitotic cohesin complex) is a cohesin complex that mediates sister chromatid cohesion during mitosis and has a subunit composition distinct from that of the meiotic cohesin complex. In practical terms, it is the mitotic-specific form of the cohesin ring, containing SMC1A, SMC3, RAD21 and STAG1/STAG2 together with accessory proteins such as PDS5A/PDS5B, WAPL and ESCO1/ESCO2, which together tether newly replicated sister chromatids and support kinetochore function until anaphase.
Why Is mitotic cohesin complex Important in Cell Biology?
The mitotic cohesin complex is essential for faithful chromosome segregation, and its dysfunction leads to aneuploidy, chromosome instability and developmental disorders. Because cohesin also shapes the kinetochore and higher-order chromosome architecture, it is a central node in mitosis research and a recurrent mutational target in cancer. Understanding GO:0030892 therefore informs both basic chromosome biology and translational efforts in cohesinopathies and oncology.
• Maintains sister chromatid cohesion from S phase to anaphase, preventing premature chromatid separation.
• Stabilizes the CCAN complex at kinetochores, supporting microtubule attachment and segregation fidelity.
• Its removal is tightly regulated by WAPL and separase, and failure of this regulation causes chromosome missegregation.
• Germline mutations in cohesin subunits cause cohesinopathies such as Cornelia de Lange syndrome and Roberts syndrome.
• Somatic cohesin mutations are recurrent in myeloid malignancies and bladder cancer, creating therapeutic vulnerabilities.
• Distinct mitotic versus meiotic cohesin compositions make GO:0030892 a useful specificity marker in comparative studies.
• Cohesin contributes to 3D genome organization and gene regulation, extending its relevance beyond cohesion.
• CRISPR-based models allow dissection of subunit-specific and domain-specific functions in mitosis.
Core Biology of GO:0030892 (mitotic cohesin complex)
What Happens During mitotic cohesin complex?
In simple terms: Cohesin is loaded onto DNA, holds sister chromatids together, and is then removed in a controlled way so chromosomes can separate.
During mitosis, the mitotic cohesin complex is loaded onto chromatin in G1 and establishes cohesion during S phase, tethering newly replicated sister chromatids. At mitotic entry, a large fraction of cohesin is removed from chromosome arms through a WAPL- and phosphorylation-dependent pathway, while centromeric cohesin is protected until anaphase. At anaphase, separase cleaves the remaining RAD21 subunit, opening the ring and allowing sister chromatids to segregate. This two-step removal ensures that cohesion is maintained until the metaphase-to-anaphase transition.
Cohesin loading and establishment of cohesion
In simple terms: Loading factors open the cohesin ring and place it on DNA, then acetylation locks it around sister chromatids.
Cohesin loading requires the SMC1A-SMC3 heterodimer, RAD21 and a STAG subunit, together with the NIPBL-MAU2 loader complex. Once loaded, cohesion is established during DNA replication, and ESCO1/ESCO2-mediated acetylation of SMC3 stabilizes the ring in a cohesive state. WAPL antagonizes this stable state by promoting cohesin release, so the balance between ESCO-mediated acetylation and WAPL activity determines how much cohesin remains chromatin-bound.
Structure and Composition of mitotic cohesin complex
In simple terms: The cohesin ring is made of SMC proteins and RAD21, with STAG and PDS5/WAPL proteins attached to control it.
The mitotic cohesin complex is a ring-shaped ATPase built from SMC1A and SMC3 heterodimers, bridged by RAD21 (and its paralogs) to form a tripartite ring. STAG1 or STAG2 binds RAD21 and contributes to chromatin engagement, while PDS5A/PDS5B and WAPL form a regulatory subcomplex that controls ring dynamics. ESCO1/ESCO2 acetyltransferases modify SMC3, and separase (ESPL1) cleaves RAD21 at anaphase. This composition is distinct from meiotic cohesin, which uses meiosis-specific subunits such as STAG3 and REC8.
Molecular Mechanism of mitotic cohesin complex
In simple terms: Cohesin uses ATP-driven ring opening and closing, plus acetylation and phosphorylation switches, to hold or release DNA.
SMC1A and SMC3 contain ATP-binding cassettes whose ATP hydrolysis drives conformational changes required for DNA entrapment and release. WAPL binds PDS5 and RAD21 to promote ring opening and cohesin turnover, and its interaction with cohesin is essential for timely cohesion dissolution. Phosphorylation of cohesin subunits and accessory factors at mitotic entry enhances WAPL-dependent removal from chromosome arms, whereas centromeric cohesin is protected by shugoshin-PP2A and only cleaved by separase at anaphase. This multilayered regulation ensures that cohesion is both stable and reversible.
Cohesin at the kinetochore and mitotic chromosome axis
In simple terms: Cohesin also helps build the kinetochore, the structure that attaches chromosomes to the spindle.
Beyond sister chromatid cohesion, mitotic cohesin stabilizes the constitutive centromere-associated network (CCAN) at kinetochores, thereby supporting kinetochore architecture and microtubule attachment. Cohesin also engages with condensin to shape mitotic chromosome assembly, and the interplay between these complexes governs chromosome compaction and resolution. These non-canonical roles link GO:0030892 to chromosome segregation fidelity and to the broader mechanics of mitosis.
Key Genes Involved in GO:0030892 mitotic cohesin complex
The following genes and proteins are core components or regulators of the mitotic cohesin complex (GO:0030892) and are commonly studied in mitosis and cohesinopathy research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SMC1A | Core SMC subunit of the cohesin ring | Mutations cause Cornelia de Lange syndrome; target for KO and point-mutation studies |
| SMC3 | Core SMC subunit; acetylation site for cohesion establishment | Central to cohesion establishment and WAPL regulation |
| RAD21 | Kleisin subunit bridging SMC1A-SMC3; cleaved by separase | Essential for cohesion; cleavage required for anaphase |
| STAG1 | Mitotic cohesin subunit (SA1) | Defines mitotic cohesin composition; studied in chromosome segregation |
| STAG2 | Mitotic cohesin subunit (SA2); frequently mutated in cancer | Recurrent somatic mutations in myeloid malignancies and bladder cancer |
| STAG3 | Meiosis-specific cohesin subunit; mitotic STAG3-cohesin reported in germline | Distinguishes meiotic vs mitotic complexes; germline nucleome studies |
| REC8 | Meiosis-specific kleisin | Comparative marker for meiotic vs mitotic cohesin |
| PDS5A | Cohesin accessory factor | Regulates cohesin dynamics with WAPL |
| PDS5B | Cohesin accessory factor | Regulates cohesin dynamics with WAPL |
| WAPL | Cohesin release factor | Promotes cohesin turnover and arm removal |
| ESCO1 | SMC3 acetyltransferase | Stabilizes cohesive cohesin |
| ESCO2 | SMC3 acetyltransferase | Mutations cause Roberts syndrome |
| NIPBL | Cohesin loader | Mutations cause Cornelia de Lange syndrome |
| MAU2 | Cohesin loader partner of NIPBL | Required for cohesin loading |
| ESPL1 | Separase; cleaves RAD21 at anaphase | Controls cohesion dissolution |
| CCAN components | Kinetochore network stabilized by cohesin | Links cohesin to kinetochore function |
How Is mitotic cohesin complex Regulated?
Mitotic cohesin function is regulated at multiple levels. Loading depends on NIPBL-MAU2, while ESCO1/ESCO2-mediated acetylation of SMC3 stabilizes the cohesive state. WAPL, in complex with PDS5A/PDS5B, promotes cohesin release and is antagonized by SMC3 acetylation. At mitotic entry, phosphorylation of cohesin and its regulators enhances WAPL-dependent removal from chromosome arms, whereas centromeric cohesin is protected by shugoshin-PP2A until anaphase. Finally, separase (ESPL1) cleaves RAD21 to trigger anaphase, and this cleavage is tightly coupled to cell cycle checkpoints.
mitotic cohesin complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NIPBL | Cornelia de Lange syndrome | Knockout or point-mutation iPSC model |
| SMC1A | Cornelia de Lange syndrome | Knock-in of patient variants in cell lines |
| ESCO2 | Roberts syndrome | Knockout and rescue with wild-type ESCO2 |
| STAG2 | Myeloid malignancies and bladder cancer | Knockout in cancer cell lines and xenografts |
| STAG3 | Male germline nucleome and fertility | Germline-specific knockout models |
Cohesinopathies: Cornelia de Lange syndrome and Roberts syndrome
Germline mutations in cohesin subunits and regulators cause developmental cohesinopathies. Cornelia de Lange syndrome is most often linked to NIPBL mutations, but SMC1A and SMC3 mutations also contribute, while Roberts syndrome is caused by ESCO2 mutations. These disorders highlight the non-redundant roles of the mitotic cohesin complex in development and genome stability.
Cancer: somatic cohesin mutations and therapeutic vulnerabilities
Somatic mutations in cohesin complex subunits, particularly STAG2, are recurrent in myeloid malignancies and bladder cancer, and can confer therapeutic vulnerabilities. Because mitotic cohesin is required for faithful chromosome segregation, its loss promotes aneuploidy and chromosome instability, making it an attractive target for precision oncology.
Germline and reproductive biology
A mitotic STAG3-cohesin complex has been described in the male germline, where it shapes the nucleome and contributes to germ cell development. This expands the disease relevance of GO:0030892 beyond canonical mitotic cells and into reproductive biology.
From mitotic cohesin complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a subunit essential for mitotic cohesion? | CRISPR knockout cell line with live-cell imaging |
| Does a patient variant impair cohesin function? | Point-mutation knock-in of the variant |
| Where and when does cohesin bind chromatin? | Tagged knock-in (e.g., GFP or degron) for imaging and ChIP |
| Does overexpression alter chromosome segregation? | Doxycycline-inducible overexpression cell line |
| Which genes buffer cohesin loss? | CRISPR library screening in cohesin-mutant backgrounds |
| How does cohesin loss affect kinetochore composition? | KO plus proteomics of kinetochore fractions |
How to Study the mitotic cohesin complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Cohesion and segregation dynamics | Tracking sister chromatid separation in mitosis |
| ChIP-seq | Cohesin binding sites on chromatin | Mapping centromeric vs arm cohesin |
| Mass spectrometry | Protein composition and interactions | Defining mitotic cohesin complex subunits |
| Hi-C | 3D genome organization | Assessing cohesin-dependent chromatin loops |
| CRISPR knockout | Gene essentiality and phenotype | Testing subunit requirement in mitosis |
| CRISPR library screening | Genetic dependencies and synthetic lethality | Identifying vulnerabilities in cohesin-mutant cancer |
| RNA-seq | Transcriptional consequences | Evaluating gene expression changes after cohesin loss |
| Proximity labeling | Local protein neighborhoods | Mapping kinetochore-cohesin interactions |
Live-cell imaging of chromosome segregation
Live-cell imaging of fluorescently tagged histones or cohesin subunits allows direct measurement of sister chromatid cohesion and segregation errors in mitosis. Tagged knock-in lines are particularly useful for tracking cohesin dynamics at centromeres and chromosome arms.
Proteomics and interactome analysis
Affinity purification and mass spectrometry of cohesin subunits can define the composition of the mitotic cohesin complex and its associated kinetochore proteins, including CCAN components. These approaches help distinguish mitotic from meiotic cohesin complexes.
Chromosome conformation and nucleome mapping
Hi-C and related nucleome mapping methods reveal how cohesin shapes 3D genome organization during mitosis and in germline cells. Such data link GO:0030892 to higher-order chromosome architecture.
CRISPR screening and functional genomics
CRISPR knockout and interference screens can identify genetic dependencies and synthetic lethal interactions in cohesin-mutant cells, informing therapeutic strategies. These screens are especially powerful when combined with chromosome instability readouts.
How CRISPR Can Be Used to Study GO:0030892 mitotic cohesin complex
Knockout
CRISPR knockout of SMC1A, SMC3, RAD21, STAG1 or STAG2 can reveal essential roles in sister chromatid cohesion and kinetochore stability. Because complete loss of core subunits is often lethal, inducible or conditional knockout systems are preferred for studying mitotic phenotypes.
Point Mutation
Point-mutation knock-in of patient-derived variants (for example in SMC1A, SMC3 or ESCO2) allows separation of catalytic versus structural functions and modeling of cohesinopathies. Such models are useful for testing whether a specific residue controls acetylation, ATP hydrolysis or WAPL binding.
Knock-in
Tagged knock-in of cohesin subunits with fluorescent or degron tags enables real-time tracking and rapid depletion, providing dynamic information about loading, turnover and removal. These lines are valuable for live-cell imaging of mitotic cohesin behavior.
Overexpression
Overexpression of cohesin subunits or regulators such as WAPL can perturb the stoichiometry of the complex and reveal dosage-sensitive phenotypes in chromosome segregation. Inducible overexpression systems help avoid adaptation artifacts.
How EDITGENE Supports mitotic cohesin complex Research
Researchers studying mitotic cohesin complex-related genes often need to determine whether a candidate gene is causally involved in cohesion, kinetochore function or chromosome segregation, and which domain or residue mediates the phenotype. This requires precise, isogenic cell models that can separate loss-of-function, gain-of-function and patient-variant effects in a controlled background.
Contact EDITGENE today to design your custom CRISPR model for mitotic cohesin complex research.
Frequently Asked Questions About mitotic cohesin complex
What is the mitotic cohesin complex (GO:0030892)?
It is a cohesin complex that mediates sister chromatid cohesion during mitosis and has a subunit composition distinct from the meiotic cohesin complex.
What genes are involved in the mitotic cohesin complex?
Core genes include SMC1A, SMC3, RAD21, STAG1 and STAG2, with regulators such as WAPL, PDS5A, PDS5B, ESCO1, ESCO2 and ESPL1.
How is the mitotic cohesin complex different from meiotic cohesin?
Mitotic cohesin uses STAG1/STAG2 and RAD21, whereas meiotic cohesin uses meiosis-specific subunits such as STAG3 and REC8.
What is the function of cohesin in mitosis?
It holds sister chromatids together from S phase to anaphase and stabilizes the kinetochore-associated CCAN complex.
How is cohesin removed during mitosis?
Most cohesin is removed from chromosome arms by a WAPL-dependent pathway, while centromeric cohesin is cleaved by separase at anaphase.
What diseases are linked to cohesin mutations?
Cohesinopathies such as Cornelia de Lange syndrome and Roberts syndrome, as well as myeloid malignancies and bladder cancer, are linked to cohesin mutations.
Which experimental models are used to study mitotic cohesin?
CRISPR knockout, point-mutation knock-in, tagged knock-in, overexpression cell lines, live-cell imaging and CRISPR screens are commonly used.
What methods measure cohesin binding and dynamics?
ChIP-seq, live-cell imaging, mass spectrometry, Hi-C and proximity labeling are widely used.
Why is STAG2 frequently mutated in cancer?
STAG2 is a recurrent somatic mutational target in myeloid malignancies and bladder cancer, and its loss creates therapeutic vulnerabilities.
Can cohesin have non-cohesion roles in mitosis?
Yes, cohesin stabilizes the CCAN at kinetochores and cooperates with condensin in mitotic chromosome assembly.
Conclusion
The mitotic cohesin complex (GO:0030892) is a dynamic, multi-subunit ring that ensures sister chromatid cohesion and supports kinetochore function during mitosis. Its composition, regulation by WAPL, ESCO and separase, and its links to cohesinopathies and cancer make it a central topic in chromosome biology. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with imaging, proteomics and screening, provide the tools needed to dissect its mechanism and translational potential.
References
- 1. Nagano M et al.. 2025. The mitotic STAG3-cohesin complex shapes male germline nucleome.. Nat Struct Mol Biol 32(11):2203-2218 PMID: 40855131
- 2. Piché J et al.. 2019. The expanding phenotypes of cohesinopathies: one ring to rule them all!. Cell Cycle 18(21):2828-2848 PMID: 31516082
- 3. Paulson JR et al.. 2021. Mitotic chromosomes.. Semin Cell Dev Biol 117:7-29 PMID: 33836947
- 4. Haase J et al.. 2025. Cohesin-mediated stabilization of the CCAN complex at kinetochores in mitosis.. Curr Biol 35(16):3943-3958.e5 PMID: 40730158
- 5. Yuan X et al.. 2024. Molecular mechanism and functional significance of Wapl interaction with the Cohesin complex.. Proc Natl Acad Sci U S A 121(33):e2405177121 PMID: 39110738
- 6. Liu Y et al.. 2018. Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer.. J Clin Invest 128(7):2951-2965 PMID: 29649003
- 7. Howard-Till RA et al.. 2013. A single cohesin complex performs mitotic and meiotic functions in the protist tetrahymena.. PLoS Genet 9(3):e1003418 PMID: 23555314
- 8. Yan H et al.. 2025. Decoding Mitotic Chromosome Assembly: Three Rules Governing Condensin-Cohesin Engagement.. Research (Wash D C) 8:0812 PMID: 40837874
